Johnson & Jonson secures FDA approval for multiple myeloma treatment
Support for first and only high-risk smouldering multiple myeloma treatment came from positive phase 3 trial results
Read More
Section: Healthcare
AstraZeneca reports positive results from phase 3 blood pressure trial
The study demonstrated reduction in systolic blood pressure compared to placebo in patient with hypertension
Read More
Novo Nordisk agrees to lower certain drug prices in the US
The company’s semaglutide-based weight-loss drugs will be made available in the US through Medicare and Medicaid
Read More
Lilly announces agreement with US government to lower patient costs
The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient channels
Read More
Boehringer Ingelheim and CDR-Life agree on deal worth up to $570m
The deal focuses on T cell-based therapies for autoimmune disease
Read More